Skip to the page

Data / Form D filings / ATHERSYS, INC / NEW

ATHERSYS, INC / NEW: Form D filings

ATHERSYS, INC / NEW, a biotechnology company in Cleveland, OH, filed 2 Form D notices with the SEC between 2012 and 2023. The latest, on May 1, 2023, reports $3.5 million sold of a $3.5 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3201 CARNEGIE AVENUE, Cleveland, OH, 44115
Phone
(216) 431-9900
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1368148

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 1, 2023New notice$3,537,600$3,537,6004Apr 18, 2023sec.gov
Mar 22, 2012New notice$18,000,004$9,000,002$9,000,00220Mar 9, 2012sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
ISMAIL KOLADirector
DANIEL CAMARDOExecutive Officer, Director
JACK WYSZOMIERSKIDirector
JOSEPH NOLANDirector
KASEY ROSADOExecutive Officer
MAIA HANSENExecutive Officer
JANE WASMANDirector

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of May 1, 2023 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ATHERSYS, INC / NEW reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.